Serveur d'exploration Tocilizumab

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Italie And NotPaola Cipriani

List of bibliographic references

Number of relevant bibliographic references: 78.
Ident.Authors (with country if any)Title
000013 Daniela Marotto [Italie] ; Piercarlo Sarzi-Puttini [Italie]What is the role of rheumatologists in the era of COVID-19?
000022 Luca Quartuccio [Italie] ; Luca Semerano [France] ; Maurizio Benucci [Italie] ; Marie-Christophe Boissier [France] ; Salvatore De Vita [Italie]Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome
000044 Ernest H. Choy [Royaume-Uni] ; Fabrizio De Benedetti [Italie] ; Tsutomu Takeuchi [Japon] ; Misato Hashizume [Japon] ; Markus R. John [Suisse] ; Tadamitsu Kishimoto [Japon]Translating IL-6 biology into effective treatments
000079 Caterina Vacchi [Italie] ; Marco Sebastiani [Italie] ; Giulia Cassone [Italie] ; Stefania Cerri [Italie] ; Giovanni Della Casa [Italie] ; Carlo Salvarani [Italie] ; Andreina Manfredi [Italie]Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review
000099 Carlo Perricone [Italie] ; Paola Triggianese [Italie] ; Elena Bartoloni [Italie] ; Giacomo Cafaro [Italie] ; Angelo F. Bonifacio [Italie] ; Roberto Bursi [Italie] ; Roberto Perricone [Italie] ; Roberto Gerli [Italie]The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19
000128 Sophie Testa [Italie] ; Oriana Paoletti [Italie] ; Matteo Giorgi-Pierfranceschi [Italie] ; Angelo Pan [Italie]Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients
000131 Waleed Alhazzani [Canada] ; Morten Hylander M Ller [Danemark] ; Yaseen M. Arabi ; Mark Loeb [Canada] ; Michelle Ng Gong [États-Unis] ; Eddy Fan [Canada] ; Simon Oczkowski [Canada] ; Mitchell M. Levy [États-Unis] ; Lennie Derde [Pays-Bas] ; Amy Dzierba [États-Unis] ; Bin Du [République populaire de Chine] ; Michael Aboodi [États-Unis] ; Hannah Wunsch ; Maurizio Cecconi [Italie] ; Younsuck Koh [Corée du Sud] ; Daniel S. Chertow [États-Unis] ; Kathryn Maitland [Royaume-Uni] ; Fayez Alshamsi [Émirats arabes unis] ; Emilie Belley-Cote [Canada] ; Massimiliano Greco [Italie] ; Matthew Laundy [Royaume-Uni] ; Jill S. Morgan [États-Unis] ; Jozef Kesecioglu [Pays-Bas] ; Allison Mcgeer [Canada] ; Leonard Mermel [États-Unis] ; Manoj J. Mammen [États-Unis] ; Paul E. Alexander [Canada] ; Amy Arrington [États-Unis] ; John E. Centofanti [Canada] ; Giuseppe Citerio [Italie] ; Bandar Baw [Canada, Arabie saoudite] ; Ziad A. Memish ; Naomi Hammond [Australie] ; Frederick G. Hayden [États-Unis] ; Laura Evans [États-Unis] ; Andrew Rhodes [Royaume-Uni]Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)
000132 Waleed Alhazzani [Canada] ; Morten Hylander M Ller ; Yaseen M. Arabi ; Mark Loeb [Canada] ; Michelle Ng Gong [États-Unis] ; Eddy Fan [Canada] ; Simon Oczkowski [Canada] ; Mitchell M. Levy [États-Unis] ; Lennie Derde [Pays-Bas] ; Amy Dzierba [États-Unis] ; Bin Du [République populaire de Chine] ; Michael Aboodi [États-Unis] ; Hannah Wunsch [Canada] ; Maurizio Cecconi [Italie] ; Younsuck Koh [Corée du Sud] ; Daniel S. Chertow [États-Unis] ; Kathryn Maitland [Royaume-Uni] ; Fayez Alshamsi [Émirats arabes unis] ; Emilie Belley-Cote [Canada] ; Massimiliano Greco [Italie] ; Matthew Laundy [Royaume-Uni] ; Jill S. Morgan [États-Unis] ; Jozef Kesecioglu [Pays-Bas] ; Allison Mcgeer [Canada] ; Leonard Mermel [États-Unis] ; Manoj J. Mammen [États-Unis] ; Paul E. Alexander ; Amy Arrington [États-Unis] ; John E. Centofanti [Canada] ; Giuseppe Citerio [Italie] ; Bandar Baw [Arabie saoudite] ; Ziad A. Memish ; Naomi Hammond [Australie] ; Frederick G. Hayden [États-Unis] ; Laura Evans [États-Unis] ; Andrew Rhodes [Royaume-Uni]Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)
000150 Giovanna Garufi [Italie] ; Luisa Carbognin [Italie] ; Armando Orlandi [Italie] ; Giampaolo Tortora [Italie] ; Emilio Bria [Italie]Smoking Habit and Hospitalization for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Related Pneumonia: the unsolved paradox behind the evidence.
000164 Giulia Cassone ; Andreina Manfredi ; Fabiola Atzeni ; Vincenzo Venerito ; Caterina Vacchi ; Valentina Picerno ; Federica Furini ; Gian Luca Erre ; Paola Tomietto ; Anna Laura Fedele [Italie] ; Giovanni Della Casa [Italie] ; Valeria Nucera ; Chiara Giannitti [Italie] ; Carlo Salvarani ; Marco SebastianiSafety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study
000169 Maria Antonietta Barbieri [Italie] ; Giuseppe Cicala [Italie] ; Paola Maria Cutroneo [Italie] ; Elisabetta Gerratana [Italie] ; Caterina Palleria [Italie] ; Caterina De Sarro [Italie] ; Ada Vero [Italie] ; Luigi Iannone [Italie] ; Antonia Manti [Italie] ; Emilio Russo [Italie] ; Giovambattista De Sarro [Italie] ; Fabiola Atzeni [Italie] ; Edoardo Spina [Italie]Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study.
000197 Angela Ceribelli [Italie] ; Francesca Motta [Italie] ; Maria De Santis [Italie] ; Aftab A. Ansari [États-Unis] ; William M. Ridgway [États-Unis] ; M. Eric Gershwin [États-Unis] ; Carlo Selmi [Italie]Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
000208 Natalia Maximova [Italie] ; Alessandra Maestro [Italie] ; Davide Zanon [Italie] ; Annalisa Marcuzzi [Italie]Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration
000232 Luca Quartuccio [Italie] ; Luca Semerano [France] ; Maurizio Benucci [Italie] ; Marie-Christophe Boissier [France] ; Salvatore De Vita [Italie]Pistes urgentes dans le traitement de l’infection par le COVID-19 : cibler l’inflammation en aval pour prévenir un syndrome catastrophique☆
000233 Giulia Cassone [Italie] ; Marco Sebastiani [Italie] ; Caterina Vacchi [Italie] ; Stefania Cerri [Italie] ; Carlo Salvarani [Italie] ; Andreina Manfredi [Italie]Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming?
000236 Laure Elens [Belgique] ; Loralie J. Langman [États-Unis] ; Dennis A. Hesselink ; Stein Bergan [Norvège] ; Dirk Jan A. R. Moes ; Mariadelfina Molinaro [Italie] ; Raman Venkataramanan [États-Unis] ; Florian Lemaitre [France]Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug–Drug Interactions
000247 Gabriella Giancane [Italie] ; Joost F. Swart [Pays-Bas] ; Elio Castagnola [Italie] ; Andreas H. Groll [Allemagne] ; Gerd Horneff [Allemagne] ; Hans-Iko Huppertz [Allemagne] ; Daniel J. Lovell [États-Unis] ; Tom Wolfs [Pays-Bas] ; Troels Herlin [Danemark] ; Pavla Dolezalova [République tchèque] ; Helga Sanner [Norvège] ; Gordana Susic [Serbie] ; Flavio Sztajnbok [Brésil] ; Despoina Maritsi [Grèce] ; Tamas Constantin [Hongrie] ; Veronika Vargova [Slovaquie] ; Sujata Sawhney [Inde] ; Marite Rygg [Norvège] ; Sheila K. Oliveira [Brésil] ; Marco Cattalini [Italie] ; Francesca Bovis [Italie] ; Francesca Bagnasco [Italie] ; Angela Pistorio [Italie] ; Alberto Martini [Italie] ; Nico Wulffraat [Pays-Bas] ; Nicolino Ruperto [Italie]Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild Safety Adjudication Committee
000250 Maurizio Benucci [Italie] ; Arianna Damiani [Italie] ; Maria Infantino [Italie] ; Mariangela Manfredi [Italie] ; Luca Quartuccio [Italie]Old and new antirheumatic drugs for the treatment of COVID-19
000251 Simona Di Giambenedetto ; Arturo Ciccullo ; Alberto Borghetti ; Giovanni Gambassi [Italie] ; Francesco Landi [Italie] ; Elena Visconti ; Lorenzo Zileri Dal Verme ; Roberto Bernabei [Italie] ; Enrica Tamburrini ; Roberto Cauda ; Antonio Gasbarrini [Italie]Off-label Use of Tocilizumab in Patients with SARS-CoV-2 Infection.
000255 Domenico Umberto De Rose [Italie] ; Fiammetta Piersigilli [Italie, Belgique] ; Maria Paola Ronchetti [Italie] ; Alessandra Santisi [Italie] ; Iliana Bersani [Italie] ; Andrea Dotta [Italie] ; Olivier Danhaive [Belgique] ; Cinzia Auriti [Italie]Novel Coronavirus disease (COVID-19) in newborns and infants: what we know so far
000256 Francesco Bennardo [Italie] ; Caterina Buffone [Italie] ; Amerigo Giudice [Italie]New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws.
000259 Sara Pagani [Royaume-Uni] ; Mattia Bellan [Italie] ; Daniele Mauro [Royaume-Uni] ; Luigi Mario Castello [Italie] ; Gian Carlo Avanzi [Italie] ; Myles J. Lewis [Royaume-Uni] ; Pier Paolo Sainaghi [Italie] ; Costantino Pitzalis [Royaume-Uni] ; Alessandra Nerviani [Royaume-Uni]New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis
000261 R. Tonelli [Italie] ; A. Iattoni [Italie] ; M. Girardis [Italie] ; L. De Pietri [Italie] ; E. Clini [Italie] ; C. Mussini [Italie]Never Give Up: Lesson learned from a severe COVID-19 patient
000264 Domenico Acanfora [Italie] ; Marco Matteo Ciccone [Italie] ; Pietro Scicchitano [Italie] ; Chiara Acanfora [Italie] ; Gerardo Casucci [Italie]Neprilysin inhibitor–angiotensin II receptor blocker combination (sacubitril/valsartan): rationale for adoption in SARS-CoV-2 patients
000269 Jose Manuel Sánchez-Maldonado [Espagne] ; Manuel Martínez-Bueno [Espagne] ; Helena Canhão [Portugal] ; Rob Ter Horst [Pays-Bas] ; Sonia Mu Oz-Pe A [Espagne] ; Ana Mo Iz-Díez [Espagne] ; Ana Rodríguez-Ramos [Espagne] ; Alejandro Escudero [Espagne] ; Signe B. Sorensen [Danemark] ; Merete L. Hetland [Danemark] ; Miguel A. Ferrer [Espagne] ; Bente Glintborg [Danemark] ; Ileana Filipescu [Roumanie] ; Eva Pérez-Pampin [Espagne] ; Pablo Conesa-Zamora [Espagne] ; Antonio García [Espagne] ; Alfons Den Broeder [Pays-Bas] ; Salvatore De Vita [Italie] ; Svend Erik Hove Jacobsen [Danemark] ; Eduardo Collantes [Espagne] ; Luca Quartuccio [Italie] ; Mihai G. Netea [Pays-Bas, Allemagne] ; Yang Li [Pays-Bas] ; João E. Fonseca [Portugal] ; Manuel Jurado [Espagne] ; Miguel Ngel L Pez-Nevot [Espagne] ; Marieke J. H. Coenen [Pays-Bas] ; Vibeke Andersen [Danemark] ; Rafael Cáliz [Espagne] ; Juan Sainz [Espagne]NFKB2 polymorphisms associate with the risk of developing rheumatoid arthritis and response to TNF inhibitors: Results from the REPAIR consortium
000270 Maurizio Benucci [Italie] ; Arianna Damiani [Italie] ; Maria Infantino [Italie] ; Mariangela Manfredi [Italie] ; Luca Quartuccio [Italie]Médicaments rhumatologiques pour le traitement de l’infection par le COVID-19☆
000271 Gabriella Bottari [Italie] ; Pietro Merli [Italie] ; Isabella Guzzo [Italie] ; Francesca Stoppa [Italie] ; Annalisa Ruggeri [Italie] ; Matteo Di Nardo [Italie] ; Francesca Del Bufalo [Italie] ; Federica Galaverna [Italie] ; Cecchetti Corrado [Italie] ; Franco Locatelli [Italie]Multimodal Therapeutic Approach of Cytokine Release Syndrome Developing in a Child Given Chimeric Antigen Receptor-Modified T Cell Infusion
000276 Giacomo Bellani [Italie] ; Tài Pham [France] ; John G. Laffey [Irlande (pays)]Missed or delayed diagnosis of ARDS: a common and serious problem
000283 Matteo Megna [Italie] ; Maddalena Napolitano [Italie] ; Gabriella Fabbrocini [Italie]May IL-17 have a role in COVID-19 infection?
000289 Ibrahim Yakoub-Agha [France] ; Christian Chabannon [France] ; Peter Bader [Allemagne] ; Grzegorz W. Basak [Pologne] ; Halvard Bonig [Allemagne] ; Fabio Ciceri [Italie] ; Selim Corbacioglu [Allemagne] ; Rafael F. Duarte [Espagne] ; Hermann Einsele [Allemagne] ; Michael Hudecek [Allemagne] ; Marie José Kersten [Pays-Bas] ; Ulrike Köhl [Allemagne] ; Jürgen Kuball [Pays-Bas] ; Stephan Mielke [Suède] ; Mohamad Mohty [France] ; John Murray [Royaume-Uni] ; Arnon Nagler [Israël] ; Stephen Robinson [Royaume-Uni] ; Riccardo Saccardi [Italie] ; Fermin Sanchez-Guijo [Espagne] ; John A. Snowden [Royaume-Uni] ; Micha Srour [France] ; Jan Styczynski [Pologne] ; Alvaro Urbano-Ispizua [Espagne] ; Patrick J. Hayden [Irlande (pays)] ; Nicolaus Kröger [Allemagne]Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)
000290 Federico Alberici [Italie] ; Elisa Delbarba [Italie] ; Chiara Manenti [Italie] ; Laura Econimo [Italie] ; Francesca Valerio [Italie] ; Alessandra Pola [Italie] ; Camilla Maffei [Italie] ; Stefano Possenti [Italie] ; Simone Piva [Italie] ; Nicola Latronico [Italie] ; Emanuele Focà [Italie] ; Francesco Castelli [Italie] ; Paola Gaggia [Italie] ; Ezio Movilli [Italie] ; Sergio Bove [Italie] ; Fabio Malberti [Italie] ; Marco Farina [Italie] ; Martina Bracchi [Italie] ; Ester Maria Costantino [Italie] ; Nicola Bossini [Italie] ; Mario Gaggiotti [Italie] ; Francesco Scolari [Italie]Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, Italy
000293 Hermine I. Brunner [États-Unis] ; Nikolay Tzaribachev [Allemagne] ; Gabriel Vega Cornejo ; Rik Joos [Belgique] ; Elisabeth Gervais [France] ; Rolando Cimaz [Italie] ; Inmaculada Calvo Penadés [Espagne] ; Rubén Cuttica [Argentine] ; Thomas Lutz [Allemagne] ; Pierre Quartier [France] ; Yash Gandhi [États-Unis] ; Marleen Nys [Belgique] ; Robert Wong [États-Unis] ; Alberto Martini [Italie] ; Daniel J. Lovell [États-Unis] ; Nicolino Ruperto [Italie]Maintenance of antibody response to diphtheria/tetanus vaccine in patients aged 2–5 years with polyarticular-course juvenile idiopathic arthritis receiving subcutaneous abatacept
000302 Adriana Balduzzi [Italie] ; Erica Brivio [Italie, Pays-Bas] ; Attilio Rovelli [Italie] ; Carmelo Rizzari [Italie] ; Serena Gasperini [Italie] ; Maria Luisa Melzi [Italie] ; Valentino Conter [Italie] ; Andrea Biondi [Italie]Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati
000304 Claudio Ronco [Italie] ; Thiago Reis [Italie, Brésil]Kidney involvement in COVID-19 and rationale for extracorporeal therapies
000305 Susanne H. C. Baumeister [États-Unis] ; Benedetta Rambaldi [États-Unis, Italie] ; Roman M. Shapiro [États-Unis] ; Rizwan Romee [États-Unis]Key Aspects of the Immunobiology of Haploidentical Hematopoietic Cell Transplantation
000312 Clara Camaschella [Italie] ; Antonella Nai [Italie] ; Laura Silvestri [Italie]Iron metabolism and iron disorders revisited in the hepcidin era
000338 Ivan Arias De La Rosa [Espagne] ; Carlos Perez-Sanchez [Royaume-Uni] ; Patricia Ruiz-Limon [Espagne] ; Alejandra Pati O-Trives [Espagne] ; Carmen Torres-Granados [Espagne] ; Yolanda Jimenez-Gomez [Espagne] ; Maria Del Carmen Abalos-Aguilera [Espagne] ; Irene Cecchi [Italie] ; Rafaela Ortega [Espagne] ; Miguel Angel Caracuel [Espagne] ; Jerusalem Calvo-Gutierrez [Espagne] ; Alejandro Escudero-Contreras [Espagne] ; Eduardo Collantes-Estevez [Espagne] ; Chary Lopez-Pedrera [Espagne] ; Nuria Barbarroja [Oman]Impaired microRNA processing in neutrophils from rheumatoid arthritis patients confers their pathogenic profile. Modulation by biological therapies.
000346 Jennifer M. Logue [États-Unis] ; Elisa Zucchetti [Italie] ; Christina A. Bachmeier [États-Unis] ; Gabriel S. Krivenko [États-Unis] ; Victoria Larson [États-Unis] ; Daniel Ninh [États-Unis] ; Giovanni Grillo [Italie] ; Biwei Cao [États-Unis] ; Jongphil Kim [États-Unis] ; Julio C. Chavez [États-Unis] ; Aliyah Baluch [États-Unis] ; Farhad Khimani [États-Unis] ; Aleksandr Lazaryan [États-Unis] ; Taiga Nishihori [États-Unis] ; Hien D. Liu [États-Unis] ; Javier Pinilla-Ibarz [États-Unis] ; Bijal D. Shah [États-Unis] ; Rawan Faramand [États-Unis] ; Anna E. Coghill [États-Unis] ; Marco L. Davila [États-Unis] ; Bhagirathbhai R. Dholaria [États-Unis] ; Michael D. Jain ; Frederick L. Locke [États-Unis]Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma.
000354 Chiara Minotti [Italie] ; Francesca Tirelli [Italie] ; Elisa Barbieri [Italie] ; Carlo Giaquinto [Italie] ; Daniele Donà [Italie]How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review
000363 Elisa Gremese [Italie] ; Antonio Gasbarrini [Italie] ; Gianfranco Ferraccioli [Italie]HBV and targeted synthetic (ts)DMARDs: what have we learned from bDMARDs and tsDMARDs?
000368 Rosanna Dammacco [Italie] ; Giovanni Alessio [Italie] ; Ermete Giancipoli [Italie] ; Patrizia Leone [Italie] ; Anna Cirulli [Italie] ; Leonardo Resta [Italie] ; Angelo Vacca [Italie] ; Franco Dammacco [Italie]Giant Cell Arteritis: The Experience of Two Collaborative Referral Centers and an Overview of Disease Pathogenesis and Therapeutic Advancements
000384 M. Cellina [Italie] ; M. Orsi [Italie] ; F. Bombaci [Italie] ; M. Sala [Italie] ; P. Marino [Italie] ; G. Oliva [Italie]Favorable changes of CT findings in a patient with COVID-19 pneumonia after treatment with tocilizumab.
000399 Gregorio Tersalvi [Suisse] ; Marco Vicenzi [Italie] ; Davide Calabretta [Italie] ; Luigi Biasco [Italie, Suisse] ; Giovanni Pedrazzini [Suisse] ; Dario Winterton [Italie]Elevated troponin in patients with Coronavirus Disease 2019 (COVID-19): possible mechanisms
000406 Maurizio Benucci [Italie] ; Luciana Tramacere [Italie] ; Maria Infantino [Italie] ; Mariangela Manfredi [Italie] ; Valentina Grossi [Italie] ; Arianna Damiani [Italie] ; Francesca Li Gobbi [Italie] ; Maristella Piccininni [Italie] ; Gaetano Zaccara [Italie] ; Massimo Cincotta [Italie]Efficacy of Tocilizumab in Limbic Encephalitis with Anti-CASPR2 Antibodies
000429 Josef S. Smolen [Autriche] ; Robert B M. Landewé [Pays-Bas] ; Johannes W J. Bijlsma [Pays-Bas] ; Gerd R. Burmester [Allemagne] ; Maxime Dougados [France] ; Andreas Kerschbaumer [Autriche] ; Iain B. Mcinnes [Royaume-Uni] ; Alexandre Sepriano [Pays-Bas] ; Ronald F. Van Vollenhoven [Pays-Bas] ; Maarten De Wit [Pays-Bas] ; Daniel Aletaha [Autriche] ; Martin Aringer [Allemagne] ; John Askling [Suède] ; Alejandro Balsa [Espagne] ; Maarten Boers [Pays-Bas] ; Alfons A. Den Broeder [Pays-Bas] ; Maya H. Buch [Royaume-Uni] ; Frank Buttgereit [Allemagne] ; Roberto Caporali [Italie] ; Mario Humberto Cardiel [Mexique] ; Diederik De Cock [Belgique] ; Catalin Codreanu [Roumanie] ; Maurizio Cutolo [Italie] ; Christopher John Edwards [Royaume-Uni] ; Yvonne Van Eijk-Hustings [Pays-Bas] ; Paul Emery [Royaume-Uni] ; Axel Finckh [Suisse] ; Laure Gossec [France] ; Jacques-Eric Gottenberg [France] ; Merete Lund Hetland [Danemark] ; Tom W J. Huizinga [Pays-Bas] ; Marios Koloumas [Suisse] ; Zhanguo Li [République populaire de Chine] ; Xavier Mariette [France] ; Ulf Müller-Ladner [Allemagne] ; Eduardo F. Mysler [Argentine] ; Jose A P. Da Silva [Portugal] ; Gyula Po R [Hongrie] ; Janet E. Pope [Canada] ; Andrea Rubbert-Roth [Suisse] ; Adeline Ruyssen-Witrand [France] ; Kenneth G. Saag [États-Unis] ; Anja Strangfeld [Allemagne] ; Tsutomu Takeuchi [Japon] ; Marieke Voshaar [Pays-Bas] ; René Westhovens [Belgique] ; Désirée Van Der Heijde [Pays-Bas]EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
000430 Marco A. Cimmino [Italie] ; Massimiliano Parodi [Italie] ; Francesca Barbieri [Italie] ; Stefano Bombardieri [Italie] ; Giuseppe Zampogna [Italie] ; Annamaria Iagnocco [Italie] ; Alberto Batticciotto [Italie] ; Luca Maria Sconfienza [Italie] ; Luigi Sinigaglia [Italie] ; Fabrizio De Benedetti [Italie] ; Fabiola Atzeni [Italie] ; Piercarlo Sarzi-Puttini [Italie]Dynamic Contrast-Enhanced MRI Confirms Rapid And Sustained Improvement Of Rheumatoid Arthritis Induced By Tocilizumab Treatment: An Italian Multicentre Study
000433 Corrado Campochiaro [Italie] ; Alessandro Tomelleri [Italie] ; Silvia Sartorelli [Italie] ; Giulio Cavalli [Italie] ; Giacomo De Luca [Italie] ; Elena Baldissera [Italie] ; Lorenzo Dagna [Italie]Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritis.
000440 Robert David Sandler [Royaume-Uni] ; Rachel Scarlett Tattersall [Royaume-Uni] ; Helene Schoemans [Belgique] ; Raffaella Greco [Italie] ; Manuela Badoglio [France] ; Myriam Labopin [France] ; Tobias Alexander [Allemagne] ; Kirill Kirgizov [Russie] ; Montserrat Rovira [Espagne] ; Muhammad Saif [Royaume-Uni] ; Riccardo Saccardi [Italie] ; Julio Delgado [Espagne] ; Zinaida Peric [Croatie] ; Christian Koenecke [Allemagne] ; Olaf Penack [Allemagne] ; Grzegorz Basak [Pologne] ; John Andrew Snowden [Royaume-Uni]Diagnosis and Management of Secondary HLH/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP)
000444 Stefania Costi [Italie] ; Roberto Caporali [Italie] ; Rolando Cimaz [Italie]Dealing with COVID-19 in a Pediatric Rheumatology Unit in Italy
000446 Danila Gurgone [Royaume-Uni, Italie] ; Lucy Mcshane [Royaume-Uni] ; Charles Mcsharry [Royaume-Uni] ; Tomasz J. Guzik [Royaume-Uni, Pologne] ; Pasquale Maffia [Royaume-Uni, Italie]Cytokines at the Interplay Between Asthma and Atherosclerosis?
000448 Martina Bonacini [Italie] ; Alessandra Soriano [Italie] ; Luca Cimino [Italie] ; Luca De Simone [Italie] ; Elena Bolletta [Italie] ; Fabrizio Gozzi [Italie] ; Francesco Muratore [Italie] ; Maria Nicastro [Italie] ; Lucia Belloni [Italie] ; Alessandro Zerbini [Italie] ; Luigi Fontana [Italie] ; Carlo Salvarani [Italie] ; Stefania Croci [Italie]Cytokine Profiling in Aqueous Humor Samples From Patients With Non-Infectious Uveitis Associated With Systemic Inflammatory Diseases
000453 Cristina Scavone [Italie] ; Simona Brusco [Italie] ; Michele Bertini [Italie] ; Liberata Sportiello [Italie] ; Concetta Rafaniello [Italie] ; Alice Zoccoli [Italie] ; Liberato Berrino [Italie] ; Giorgio Racagni [Italie] ; Francesco Rossi [Italie] ; Annalisa Capuano [Italie]Current pharmacological treatments for COVID-19: what's next?
000456 Francesco Fontana [Italie] ; Gaetano Alfano [Italie] ; Giacomo Mori [Italie] ; Alessio Amurri [Italie] ; Tei Lorenzo [Italie] ; Marco Ballestri [Italie] ; Marco Leonelli [Italie] ; Francesca Facchini [Italie] ; Francesca Damiano [Italie] ; Riccardo Magistroni [Italie] ; Gianni Cappelli [Italie]Covid-19 pneumonia in a kidney transplant recipient successfully treated with Tocilizumab and Hydroxychloroquine.
000471 Giuseppe Di Lorenzo [Italie] ; Rossella Di Trolio [Italie]Coronavirus Disease (COVID-19) in Italy: Analysis of Risk Factors and Proposed Remedial Measures
000484 Martina Pennisi [États-Unis, Italie] ; Tania Jain [États-Unis] ; Bianca D. Santomasso [États-Unis] ; Elena Mead [États-Unis] ; Kitsada Wudhikarn [États-Unis, Thaïlande] ; Mari Lynne Silverberg [États-Unis] ; Yakup Batlevi [États-Unis] ; Roni Shouval [États-Unis] ; Sean M. Devlin ; Connie Batlevi [États-Unis] ; Renier J. Brentjens [États-Unis] ; Parastoo B. Dahi [États-Unis] ; Claudia Diamonte [États-Unis] ; Sergio Giralt [États-Unis] ; Elizabeth F. Halton [États-Unis] ; Molly Maloy [États-Unis] ; Maria Lia Palomba [États-Unis] ; Miriam Sanchez-Escamilla [États-Unis, Espagne] ; Craig S. Sauter [États-Unis] ; Michael Scordo [États-Unis] ; Gunjan Shah [États-Unis] ; Jae H. Park [États-Unis] ; Miguel-Angel Perales [États-Unis]Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management
000485 Kim Lauper [Suisse] ; Denis Mongin [Suisse] ; Florenzo Iannone [Italie] ; Eirik K. Kristianslund [Norvège] ; Tore K. Kvien [Norvège] ; Dan C. Nordström [Finlande] ; Karel Pavelka [République tchèque] ; Manuel Pombo-Suarez [Espagne] ; Ziga Rotar [Slovénie] ; Maria J. Santos [Portugal] ; Catalin Codreanu [Roumanie] ; Galina Lukina [Russie] ; Sara L. Gale [États-Unis] ; Markus John [Suisse] ; Yves Luder [Suisse] ; Delphine S. Courvoisier [Suisse] ; Cem Gabay [Suisse]Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritis.
000489 R. Ferrari [Italie] ; G. Di Pasquale [Italie] ; C. Rapezzi [Italie]Commentary: What is the relationship between Covid-19 and cardiovascular disease?
000496 Simone Piva [Italie] ; Matteo Filippini [Italie] ; Fabio Turla [Italie] ; Sergio Cattaneo [Italie] ; Alessio Margola [Italie] ; Silvia De Fulviis [Italie] ; Ida Nardiello [Italie] ; Alessandra Beretta [Italie] ; Laura Ferrari [Italie] ; Raffaella Trotta [Italie] ; Gloria Erbici [Italie] ; Emanuele Focà [Italie] ; Francesco Castelli [Italie] ; Frank Rasulo [Italie] ; Michael J. Lanspa [États-Unis] ; Nicola Latronico [Italie]Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy.
000501 Marta Colaneri [Italie] ; Paolo Sacchi [Italie] ; Valentina Zuccaro [Italie] ; Simona Biscarini [Italie] ; Michele Sachs [Italie] ; Silvia Roda [Italie] ; Teresa Chiara Pieri [Italie] ; Pietro Valsecchi [Italie] ; Antonio Piralla [Italie] ; Elena Seminari [Italie] ; Angela Di Matteo [Italie] ; Stefano Novati [Italie] ; Laura Maiocchi [Italie] ; Layla Pagnucco [Italie] ; Marcello Tirani [Italie] ; Fausto Baldanti [Italie] ; Francesco Mojoli [Italie] ; Stefano Perlini [Italie] ; Raffaele Bruno [Italie]Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020
000505 Giulia Lanzolla [Italie] ; Guia Vannucchi [Italie] ; Ilaria Ionni [Italie] ; Irene Campi [Italie] ; Federica Sileo [Italie] ; Elisa Lazzaroni [Italie] ; Michele Marin [Italie]Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy
000516 Vincenzo Occhipinti [Italie] ; Luca Pastorelli [Italie]Challenges in the Care of IBD Patients During the CoViD-19 Pandemic: Report From a “Red Zone” Area in Northern Italy
000519 Tobias Boettler [Allemagne] ; Philip N. Newsome [Royaume-Uni] ; Mario U. Mondelli [Italie] ; Mojca Maticic [Slovénie] ; Elisa Cordero [Espagne] ; Markus Cornberg [Allemagne] ; Thomas Berg [Allemagne]Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper
000526 Elena Carboni [Italie] ; Anna Rosa Carta [Italie] ; Ezio Carboni [Italie]Can pioglitazone be potentially useful therapeutically in treating patients with covid-19?
000539 Ennio Giulio Favalli [Italie] ; Francesca Ingegnoli [Italie] ; Orazio De Lucia [Italie] ; Gilberto Cincinelli [Italie] ; Rolando Cimaz [Italie] ; Roberto Caporali [Italie]COVID-19 infection and rheumatoid arthritis: Faraway, so close!
000540 Paola Rizzo [Italie] ; Francesco Vieceli Dalla Sega [Italie] ; Francesca Fortini [Italie] ; Luisa Marracino [Italie] ; Claudio Rapezzi [Italie] ; Roberto Ferrari [Italie]COVID-19 in the heart and the lungs: could we “Notch” the inflammatory storm?
000545 Giovanni Novi [Italie] ; Malgorzata Mikulska [Italie] ; Federica Briano [Italie] ; Federica Toscanini [Italie] ; Francesco Tazza [Italie] ; Antonio Uccelli [Italie] ; Matilde Inglese [Italie]COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
000548 Nicola Decaro [Italie] ; Vito Martella [Italie] ; Linda J. Saif [États-Unis] ; Canio Buonavoglia [Italie]COVID-19 from veterinary medicine and one health perspectives: What animal coronaviruses have taught us
000550 Francesco Licciardi [Italie] ; Teresa Giani [Italie] ; Letizia Baldini [Italie] ; Ennio Giulio Favalli [Italie] ; Roberto Caporali [Italie] ; Rolando Cimaz [Italie]COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country
000552 Tomasz J. Guzik [Royaume-Uni] ; Saidi A. Mohiddin [Royaume-Uni] ; Anthony Dimarco [Royaume-Uni] ; Vimal Patel [Royaume-Uni] ; Kostas Savvatis [Royaume-Uni] ; Federica M. Marelli-Berg [Royaume-Uni] ; Meena S. Madhur [États-Unis] ; Maciej Tomaszewski [Royaume-Uni] ; Pasquale Maffia [Royaume-Uni] ; Fulvio D'Acquisto [Royaume-Uni] ; Stuart A. Nicklin [Royaume-Uni] ; Ali J. Marian [États-Unis] ; Ryszard Nosalski [Royaume-Uni] ; Eleanor C. Murray [Royaume-Uni] ; Bartlomiej Guzik [Pologne] ; Colin Berry [Royaume-Uni] ; Rhian M. Touyz [Royaume-Uni] ; Reinhold Kreutz [Allemagne] ; Dao Wen Wang [République populaire de Chine] ; David Bhella [Royaume-Uni] ; Orlando Sagliocco [Italie] ; Filippo Crea [Italie] ; Emma C. Thomson [Royaume-Uni] ; Iain B. Mcinnes [Royaume-Uni]COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options.
000564 Fabrizio Cantini [Italie] ; Laura Niccoli [Italie] ; Daniela Matarrese [Italie] ; Emanuele Nicastri [Italie] ; Paolo Stobbione [Italie] ; Delia Goletti [Italie]Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
000576 Fabrizio Dal Moro [Italie] ; Ugolino Livi [Italie]Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology
000582 Franco Maria Buonaguro [Italie] ; Igor Puzanov [États-Unis] ; Paolo Antonio Ascierto [Italie]Anti-IL6R role in treatment of COVID-19-related ARDS
000598 Angelo Fassio [Italie] ; Giovanni Adami [Italie] ; Alessandro Giollo [Italie] ; Ombretta Viapiana [Italie] ; Nazzarena Malavolta [Italie] ; Gianantonio Saviola [Italie] ; Roberto Bortolotti [Italie] ; Luca Idolazzi [Italie] ; Francesco Bertoldo [Italie] ; Maurizio Rossini [Italie] ; Davide Gatti [Italie]Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study.
000602 Federico Alberici [Italie] ; Elisa Delbarba [Italie] ; Chiara Manenti [Italie] ; Laura Econimo [Italie] ; Francesca Valerio [Italie] ; Alessandra Pola [Italie] ; Camilla Maffei [Italie] ; Stefano Possenti [Italie] ; Nicole Zambetti [Italie] ; Marianna Moscato [Italie] ; Margherita Venturini [Italie] ; Stefania Affatato [Italie] ; Mario Gaggiotti [Italie] ; Nicola Bossini [Italie] ; Francesco Scolari [Italie]A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia.
000603 Anca Oana Docea [Roumanie] ; Aristidis Tsatsakis [Grèce, Russie, États-Unis] ; Dana Albulescu ; Oana Cristea [Roumanie] ; Ovidiu Zlatian [Roumanie] ; Marco Vinceti [Italie, États-Unis] ; Sterghios A. Moschos [Royaume-Uni] ; Dimitris Tsoukalas [Grèce] ; Marina Goumenou [Grèce] ; Nikolaos Drakoulis [Grèce] ; Josef M. Dumanov [États-Unis] ; Victor A. Tutelyan [Russie] ; Gennadii G. Onischenko [Russie] ; Michael Aschner [Russie, États-Unis] ; Demetrios A. Spandidos [Grèce] ; Daniela Calina [Roumanie]A new threat from an old enemy: Re-emergence of coronavirus (Review)
000613 Bernhard Hellmich [Allemagne] ; Ana Agueda [Portugal] ; Sara Monti [Italie] ; Frank Buttgereit [Allemagne] ; Hubert De Boysson [France] ; Elisabeth Brouwer [Pays-Bas] ; Rebecca Cassie [Royaume-Uni] ; Maria C. Cid [Espagne] ; Bhaskar Dasgupta [Royaume-Uni] ; Christian Dejaco [Autriche] ; Gulen Hatemi [Turquie] ; Nicole Hollinger [Allemagne] ; Alfred Mahr [France] ; Susan P. Mollan [Royaume-Uni] ; Chetan Mukhtyar [Royaume-Uni] ; Cristina Ponte [Portugal] ; Carlo Salvarani [Italie] ; Rajappa Sivakumar [Inde] ; Xinping Tian [République populaire de Chine] ; Gunnar Tomasson [Islande] ; Carl Turesson [Suède] ; Wolfgang Schmidt [Allemagne] ; Peter M. Villiger [Suisse] ; Richard Watts [Royaume-Uni] ; Chris Young [Royaume-Uni] ; Raashid Ahmed Luqmani [Royaume-Uni]2018 Update of the EULAR recommendations for the management of large vessel vasculitis.
000618 Maurizio Benucci [Italie] ; Valentina Grossi [Italie] ; Mariangela Manfredi [Italie] ; Arianna Damiani [Italie] ; Maria Infantino [Italie] ; Paolo Moscato [Italie] ; Luigi Cinquanta [Italie] ; Elisa Gremese [Italie] ; Barbara Tolusso [Italie] ; Luca Petricca [Italie] ; Anna Laura Fedele [Italie] ; Stefano Alivernini [Italie] ; Fabiola Atzeni [Italie] ; Giovanni Minisola [Italie] ; Roberto Verna [Italie]Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity
000636 Melissa Bersanelli [Italie]Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021